---
title: Characteristics and prognosis of patients with primary metastatic disease vs.
  recurrent HER2-negative, hormone receptor-positive advanced breast cancer
date: '2025-02-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39952220/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250215170745&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: HRpos/HER2neg first-line MBC patients have a more favorable
  prognosis if the disease was previously not treated. This difference was similar
  across all examined clinicopathological parameters. It may therefore be beneficial
  to incorporate MBC categories as a stratification factor in clinical ...'
disable_comments: true
---
CONCLUSION: HRpos/HER2neg first-line MBC patients have a more favorable prognosis if the disease was previously not treated. This difference was similar across all examined clinicopathological parameters. It may therefore be beneficial to incorporate MBC categories as a stratification factor in clinical ...